{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:30:32Z","timestamp":1790101832967,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Research Project of Chongqing Health Commission","award":["NO. 2022MSXM141"],"award-info":[{"award-number":["NO. 2022MSXM141"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05707-4","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T03:04:41Z","timestamp":1746241481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of congenital heart disease on clinical outcomes of oral propranolol therapy for Infantile hemangiomas: a propensity score-matched analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Junsong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"5707_CR1","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez Bandera AI, Sebaratnam DF, et al. Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment. J Am Acad Dermatol. 2021;85(6):1379\u20131392. https:\/\/doi.org\/10.1016\/j.jaad.2021.08.019.","DOI":"10.1016\/j.jaad.2021.08.019"},{"issue":"10089","key":"5707_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(16)00645-0.","journal-title":"Lancet"},{"key":"5707_CR3","doi-asserted-by":"publisher","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649\u201351. https:\/\/doi.org\/10.1056\/NEJMc0708819.","DOI":"10.1056\/NEJMc0708819"},{"issue":"6","key":"5707_CR4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3783","volume":"141","author":"C Droitcourt","year":"2018","unstructured":"Droitcourt C, Kerbrat S, Rault C, et al. Safety of Oral Propranolol for Infantile Hemangioma. Pediatrics. 2018;141(6): e20173783. https:\/\/doi.org\/10.1542\/peds.2017-3783.","journal-title":"Pediatrics"},{"issue":"8","key":"5707_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1404710.","journal-title":"N Engl J Med"},{"issue":"5","key":"5707_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/SAP.0000000000000506","volume":"76","author":"L Chang","year":"2016","unstructured":"Chang L, Ye X, Qiu Y, et al. Is Propranolol Safe and Effective for Outpatient Use for Infantile Hemangioma? A Prospective Study of 679 Cases From One Center in China. Ann Plast Surg. 2016;76(5):559\u201363. https:\/\/doi.org\/10.1097\/SAP.0000000000000506.","journal-title":"Ann Plast Surg"},{"issue":"2","key":"5707_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00431-020-03872-5","volume":"180","author":"G Frongia","year":"2021","unstructured":"Frongia G, Byeon JO, Mehrabi A, et al. Recurrence rate of infantile hemangioma after oral propranolol therapy. Eur J Pediatr. 2021;180(2):585\u201390. https:\/\/doi.org\/10.1007\/s00431-020-03872-5.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"5707_CR8","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jaad.2015.01.034","volume":"72","author":"HS You","year":"2015","unstructured":"You HS, Kim HS, Kim BS, et al. Propranolol to treat infantile hemangioma (IH) in patients with congenital heart disease. J Am Acad Dermatol. 2015;72(5):912\u20134. https:\/\/doi.org\/10.1016\/j.jaad.2015.01.034.","journal-title":"J Am Acad Dermatol"},{"key":"5707_CR9","unstructured":"ISSVA Classification. Available online:\u00a0https:\/\/www.issva.org\/classification\u00a0. Accessed on 28 October 2024."},{"issue":"4","key":"5707_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.annder.2021.03.004","volume":"148","author":"C B\u00f6rjesson","year":"2021","unstructured":"B\u00f6rjesson C, Malloizel-Delaunay J, Onnis G, et al. Value of Doppler ultrasound scans in deciding whether to treat infantile haemangioma with oral propranolol. Ann Dermatol Venereol. 2021;148(4):233\u20137. https:\/\/doi.org\/10.1016\/j.annder.2021.03.004.","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"5707_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/00006534-199704001-00014","volume":"99","author":"BM Achauer","year":"1997","unstructured":"Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997;99(5):1301\u20138. https:\/\/doi.org\/10.1097\/00006534-199704001-00014.","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"5707_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012030","volume":"8","author":"T Wang","year":"2019","unstructured":"Wang T, Chen L, Yang T, et al. Congenital Heart Disease and Risk of Cardiovascular Disease: A Meta-Analysis of Cohort Studies. J Am Heart Assoc. 2019;8(10): e012030. https:\/\/doi.org\/10.1161\/JAHA.119.012030.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"5707_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.pcl.2020.06.007","volume":"67","author":"DA Burkett","year":"2020","unstructured":"Burkett DA. Common Left-to-Right Shunts. Pediatr Clin North Am. 2020;67(5):821\u201342. https:\/\/doi.org\/10.1016\/j.pcl.2020.06.007.","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"5707_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12519-019-00327-2","volume":"16","author":"Y Ding","year":"2020","unstructured":"Ding Y, Zhang JZ, Yu SR, et al. Risk factors for infantile hemangioma: a meta-analysis. World J Pediatr. 2020;16(4):377\u201384. https:\/\/doi.org\/10.1007\/s12519-019-00327-2.","journal-title":"World J Pediatr"},{"issue":"2","key":"5707_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12291-013-0341-0","volume":"29","author":"YE Nassef","year":"2014","unstructured":"Nassef YE, Hamed MA, Aly HF. Inflammatory cytokines, apoptotic, tissue injury and remodeling biomarkers in children with congenital heart disease. Indian J Clin Biochem. 2014;29(2):145\u20139. https:\/\/doi.org\/10.1007\/s12291-013-0341-0.","journal-title":"Indian J Clin Biochem"},{"issue":"12","key":"5707_CR16","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.jpedsurg.2012.09.008","volume":"47","author":"Y Ji","year":"2012","unstructured":"Ji Y, Li K, Xiao X, et al. Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells. J Pediatr Surg. 2012;47(12):2216\u201323. https:\/\/doi.org\/10.1016\/j.jpedsurg.2012.09.008.","journal-title":"J Pediatr Surg"},{"issue":"1","key":"5707_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/SLA.0b013e318254ce7a","volume":"256","author":"H Chim","year":"2012","unstructured":"Chim H, Armijo BS, Miller E, et al. Propranolol induces regression of hemangioma cells through HIF-1\u03b1-mediated inhibition of VEGF-A. Ann Surg. 2012;256(1):146\u201356. https:\/\/doi.org\/10.1097\/SLA.0b013e318254ce7a.","journal-title":"Ann Surg"},{"key":"5707_CR18","doi-asserted-by":"publisher","unstructured":"Buchhorn R, Ross RD, Bartmus D, et al. Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts. Int J Cardiol. 2001;78(3):225\u201330; discussion 230\u20131. https:\/\/doi.org\/10.1016\/s0167-5273(01)00398-9.","DOI":"10.1016\/s0167-5273(01)00398-9"},{"issue":"9","key":"5707_CR19","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.3390\/ijms23095140","volume":"23","author":"P Kaulanjan-Checkmodine","year":"2022","unstructured":"Kaulanjan-Checkmodine P, Oucherif S, Prey S, et al. Is Infantile Hemangioma a Neuroendocrine Tumor? Int J Mol Sci. 2022;23(9):5140. https:\/\/doi.org\/10.3390\/ijms23095140.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5707_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","volume":"33","author":"BW Renz","year":"2018","unstructured":"Renz BW, Takahashi R, Tanaka T, et al. \u03b22 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer. Cancer Cell. 2018;33(1):75\u201390.e7. https:\/\/doi.org\/10.1016\/j.ccell.2017.11.007.","journal-title":"Cancer Cell"},{"issue":"3","key":"5707_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10549-011-1348-y","volume":"130","author":"KS Madden","year":"2011","unstructured":"Madden KS, Szpunar MJ, Brown EB. \u03b2-Adrenergic receptors (\u03b2-AR) regulate VEGF and IL-6 production by divergent pathways in high \u03b2-AR-expressing breast cancer cell lines. Breast Cancer Res Treat. 2011;130(3):747\u201358. https:\/\/doi.org\/10.1007\/s10549-011-1348-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"5707_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00403-016-1635-x","volume":"308","author":"S de Jong","year":"2016","unstructured":"de Jong S, Itinteang T, Withers AH, et al. Does hypoxia play a role in infantile hemangioma? Arch Dermatol Res. 2016;308(4):219\u201327. https:\/\/doi.org\/10.1007\/s00403-016-1635-x.","journal-title":"Arch Dermatol Res"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05707-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T15:02:33Z","timestamp":1746284553000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05707-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5707"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05707-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Research Ethics Board of Children\u2019s Hospital affiliated Chongqing Medical University (Date: 2024\/No: 257), and complied with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Given the retrospective nature of this study, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}